Antibacterial Nanoparticles Therapeutic (ANT) Study
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Health Agency, through the Walter Reed Army Institute of Research Bacterial Diseases Branch, has issued a sole source award to the University of Notre Dame for the Antibacterial Nanoparticles Therapeutic study under solicitation HT9426-26-C-E018. This research and development project focuses on testing innovative antibacterial nanoparticles with phage-mimicking properties to combat multi-drug resistant strains of Pseudomonas aeruginosa, which frequently cause severe infections in service members following battlefield injuries. The award follows a market research process involving a Request for Information and a Notice of Intent, where the University of Notre Dame was identified as the only capable respondent. The contract is categorized under NAICS code 541713 and will be performed in Silver Spring, Maryland. The procurement was executed as a non-commercial FAR Part 13 sole source award, determined to be in the best interest of the government.
General Info
Contract Value
$295,460Place of Performance
Silver Spring, MD, 20910, USASet-Aside
Award Issued Date
Documents
0AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
The Walter Reed Army Institute of Research (WRAIR), Bacterial Diseases Branch (BDB)seeks to conduct a Research and Development (R&D) study to test innovative antibacterial nanoparticles with phage-mimicking properties (PhANPs) against combat relevant multi-drug resistant (MDR) strains of Pseudomonas (P.) aeruginosa, bacterial pathogen to cause hard to treat and even deadly infections in service members after battlefield injuries. A RFI was posted pm sam.gov’s GPE on 18 March 2026 and closed on 1 April 2026, three responses were received, and the Contracting Officer’s Representative preformed a technical evaluation, two of the responses were deemed not capable for the requirement, and one, The University of Notre Dame, was deemed capable for the requirement. A Notice of Intent was posted on sam.gov’s GPE on 14 April 2026, with a closing date of 28 April 2026. No responses were received. Therefore, market research determined a non-commercial FAR RFO Part 13 sole source award to the University of Notre Dame to be in the best interest of the Government.
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Health Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
